Stonegate Investment Group, LLC Charles River Laboratories International, Inc. Transaction History
Stonegate Investment Group, LLC
- $3.35 Billion
- Q2 2024
A detailed history of Stonegate Investment Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Stonegate Investment Group, LLC holds 1,002 shares of CRL stock, worth $189,969. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,002
Previous 976
2.66%
Holding current value
$189,969
Previous $264,000
21.97%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding CRL
# of Institutions
731Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$965 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$396 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$362 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$259 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.64B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...